Clinical Trial Update: A Trial Involving Treatment of BB2603 in Subjects With Distal Subungual Onychomycosis of the Toenail [Phase 2]

View source ↗

Summary

Phase 2 trial update for BB2603 in distal subungual onychomycosis of the toenail has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Subungual Onychomycosis

Drugs mentioned

• BB2603

Snippet

Sponsor: Blueberry Therapeutics | Conditions: Distal Subungual Onychomycosis, Fungal Infection | Phase 2 | Status: COMPLETED